| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Second Department of Medicine, Johannes Gutenberg University, Mainz, Germany;
BASF Pharma, Ludwigshafen, Germany
Myocardial ischemia-reperfusion injury can be related to complement activation with generation of chemotactic agents, adhesion molecule expression, release of cytokines and oxygen-derived free radicals, and subsequent neutrophil accumulation. In the present study the cardioprotective effects of a novel highly selective small molecule C1s inhibitor (C1s-INH-248, Knoll) were examined in a rabbit model of myocardial ischemia (I) and reperfusion (R; i.e., 60 min I + 180 min R). In in vitro tests (enzyme activity and SRBC lysis) C1s-INH-248 demonstrated profound inhibitory potency. In vivo C1s-INH-248 (1 mg/kg body weight) administered 5 min before reperfusion significantly attenuated myocardial injury (31.9 ± 2.5 vs 8.9 ± 1.6% necrosis/area at risk; p < 0.01). The cardioprotective effect was dose dependent. The reduction of myocardial injury was also observed as diminished plasma creatine kinase activity in C1s-INH-248-treated animals (70.7 ± 6.8 vs 45.1 ± 3.9 U/g protein after 3 h of reperfusion, p < 0.05). Further, cardiac myeloperoxidase activity (i.e., a marker of PMN accumulation) in the ischemic and necrotic area was significantly reduced following C1s-INH-248 treatment (1.31 ± 0.23 vs 0.4 ± 0.05 U/100 mg tissue in necrotic area, p < 0.01). Thus, blocking the classical complement pathway with a highly specific and potent synthetic inhibitor of the activated C1 complex appears to be an effective mean to preserve ischemic myocardium from injury following reperfusion.
This article has been cited by other articles:
|
|
 |
|
  M. N. Busche, V. Pavlov, K. Takahashi, and G. L. Stahl Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1853 - H1859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. D. G. McGrath, M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region. J. Immunol., March 1, 2006; 176(5): 2950 - 2957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. de Vries, R. A. Matthijsen, A. A. J. H. M. van Bijnen, T. G. A. M. Wolfs, and W. A. Buurman Lysophosphatidic Acid Prevents Renal Ischemia-Reperfusion Injury by Inhibition of Apoptosis and Complement Activation Am. J. Pathol., July 1, 2003; 163(1): 47 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. de Vries, J. Kohl, W. K. G. Leclercq, T. G. A. M. Wolfs, A. A. J. H. M. van Bijnen, P. Heeringa, and W. A. Buurman Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils J. Immunol., April 1, 2003; 170(7): 3883 - 3889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Riedemann and P. A. Ward Complement in Ischemia Reperfusion Injury Am. J. Pathol., February 1, 2003; 162(2): 363 - 367. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
